Otsuka, Vera stake their claims to IgAN treatment Otsuka and Vera both have new phase 3 data on drugs for kidney disease IgA nephropathy, but can they make a mark in an increasingly crowded market

#Otsuka #Vera #IgANtreatment #VeraTherapeutics #IgAnephropathy #IgAN #ORIGINclinicaltrial #ataticept #cytokineinhibitor #BAFF #APRIL #IgANpatients #VISIONARYclinicaltrial #antiAPRILantibody #chronickidneydisease #CKD #primaryglomerulonephritis
pharmaphorum.com/news/otsuka-...